Novo and Lilly are competing to win the GLP-1 pill market as they prepare for Medicare coverage
AI disclosure
Summary
Novo Nordisk and Eli Lilly bring their longtime rivalry to GLP-1 pills and prepare to make their pitch to seniors with Medicare.